Methicillin distribution in serum and extravascular fluid and its relevance to normal and damaged heart valves

Insights

Methicillin distributes unevenly in heart valves, with higher concentrations in damaged valves. Subcutaneous tissue chambers inaccurately reflect antibiotic uptake in heart tissues and valves.

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Infectious Diseases

Background:

  • Antibiotic penetration into cardiac tissues is crucial for treating endocarditis.
  • Understanding methicillin distribution in normal versus damaged heart valves is essential for optimizing therapy.
  • Subcutaneous tissue chambers are sometimes used to estimate drug concentrations in deeper tissues.

Purpose of the Study:

  • To determine methicillin distribution in normal and damaged heart valves.
  • To assess the accuracy of subcutaneous plastic chambers in reflecting methicillin tissue uptake.
  • To investigate the relationship between methicillin infusion dose and tissue concentrations.

Main Methods:

  • Constant infusion of methicillin in New Zealand rabbits.
  • Induction of heart valve damage via left ventricular catheterization.
  • Subcutaneous implantation of perforated plastic chambers.
  • Measurement of methicillin concentrations in serum, urine, tissue chambers, heart valves, and heart muscle.

Main Results:

  • Over 80% of the methicillin dose was recovered in serum, urine, and tissues.
  • Subcutaneous chamber fluid concentrations mirrored serum concentrations at steady state.
  • Methicillin concentrations in scarred heart valves were significantly higher than in normal valves.
  • Subcutaneous chambers did not accurately represent methicillin uptake rates in heart tissues and valves.

Conclusions:

  • Methicillin uptake is altered in scarred heart valves compared to normal valves.
  • Subcutaneous tissue chambers are unreliable for estimating methicillin concentrations in heart tissues and valves.
  • Further research is needed to accurately predict antibiotic penetration into cardiac structures.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...